Liquid ventilation in the preterm neonate

Thorax

Volumn 52, Issue SUPPL. 3, 1997, Pages

  Yoxall, C W ^a   Subhedar, N V ^a   Shaw, N J ^a  

^a LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; LUNG SURFACTANT EXTRACT; NITRIC OXIDE; PERFLUOROOCTYL BROMIDE; SURFACTANT TA;

AIRWAY DYNAMICS; ARTERIAL OXYGEN TENSION; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG EFFICACY; EXTRACORPOREAL OXYGENATION; FUNCTIONAL RESIDUAL CAPACITY; HIGH FREQUENCY VENTILATION; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; INTRATRACHEAL DRUG ADMINISTRATION; LUNG COMPLIANCE; LUNG GAS EXCHANGE; NEWBORN; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; THORAX RADIOGRAPHY; TREATMENT FAILURE;

EID: 0030833363     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.2008.s3     Document Type: Review

References (53)

1. UK Collaborative ECMO Trial Group. UK collaborative trial of neonatal extracorporeal membrane oxygenation. Lancet 19963;348:75-82.
2. HiFO Study Group. Randomised study of high frequency oscillatory ventilation in infants with severe respiratory distress syndrome. J Pediatr 1993;122:609-19.
3. Ogawa Y, Miyasaka K, Kawano T, Imura S, Inukai K. Okuyama K, et al. A multicentre randomised trial of high frequency oscillatory ventilation as compared with conventional mechanical ventilation in preterm infants with respiratory failure. Early Hum Dev 1993;32:1-10.
4. Gerstmann DR, Minton SD, Stoddard RA, Meredith KS, Monaco F, Bertrand JM, et al. The Provo multicentre early high frequency oscillation trial: improved pulmonary and clinical outcome in respiratory distress syndrome. Pediatrics 1996;98:1044-57.
5. Clark RH, Yoder BA, Sell MS. Prospective, randomised comparison of high frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr 1994;124:447-54.
6. The HIFI Study Group. High frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. N Engl J Med 1989;320:88-93.
7. Clark RH, Gerstmann DR, Null DM, deLemos RA. Prospective randomised comparison of high frequency oscillatory and conventional ventilation in respiratory distress syndrome. Pediatrics 1992;89:5-12.
8. Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full term infants with hypoxaemic respiratory failure. N Engl J Med 1997;336:597-604.
9. Subhedar NV, Shaw NJ. Inhaled nitric oxide in preterm infants at high risk of developing chronic lung disease. Arch Dis Child 1997 (in press).
10. Comroe JH. Physiology of respiration. Chicago:Year Book, 1977.
11. Tooley R, Hirschl RB, Parent A, Bartlett RH. Total liquid ventilation with perfluorocarbons increases pulmonary end-expiratory volume and compliance in the setting of lung atelectasis. Crit Care Med 1996;24:268-73.
12. Shaffer TH, Greenspan JS, Wolfson MR. Liquid ventilation. In: Boynton BR, Carlo WA, Jobe AH, eds. New therapies, for neonatal respiratory failure. Cambridge: Cambridge University Press, 1994:279-301.
13. Leach CL, Greenspan JS, Rubenstein D, Shaffer TH, Wolfson MR, Jackson JC, et al. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. N Engl J Med 1996;335:761-7.
14. Clark LC, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 1966;152:1755-6.
15. Hirschl RB, Tooley R, Parent A, Johnson K, Bartlett RH. Liquid ventilation improves pulmonary function, gas exchange and lung injury in a model of respiratory failure. Ann Surg 1995;221:79-88.
16. Hirschl RB, Tooley R, Parent A, Johnson K, Bartlett RH. Improvement of gas exchange, pulmonary function and lung injury with partial liquid ventilation: a study model in a setting of severe respiratory failure. Chest 1995;108:500-8.
17. Hirschl RB, Tooley R, Parent A, Johnson K, Bartlett RH. Evaluation of gas exchange, pulmonary compliance, and lung injury during total and partial liquid ventilation in the acute respiratory distress syndrome. Crit Care Med 1996;24:1001-8.
18. Curtis SE, Peek JT, Kelly DR. Partial liquid breathing with perflubron improves arterial oxygenation in acute canine lung injury. J Appl Physiol 1993;75:2696-702.
19. Overbeck MC, Pranikoff T, Yadao CM, Hirschl RB. Efficacy of perfluorocarbon partial liquid ventilation in a large animal model of acute respiratory failure. Crit Care Med J 1996;24:1208-14.
20. Shatter TH, Rubenstein D, Moskowitz D, Delivora-Papadopoulos M. Gaseous exchange and acid-base balance in premature lambs during liquid ventilation since birth. Pediatr Res 1976;10:227-31.
21. Leach CL, Holm B, Morin FC. Partial liquid ventilation in premature lambs with respiratory distress syndrome: efficacy and comparability with exogenous surfactant. J Pediatr 1995;126:412-20.
22. Valls-I-Soler A, Wolfson MR, Kechner N, Foust R, Shatter TH. Comparison of natural surfactant and brief liquid ventilation rescue treatment in very immature lambs. Biol Neonate 1996;69:275-83.
23. Wilcox DT, Glick PL, Karamanoukain HL, Leach C, Morin FC, Fuhrman BP. Perfluorocarbon associated gas exchange inproves pulmonary mechanics, oxygenation, ventilation and allows nitric oxide delivery in the hypoplastic lung congenital diaphragmatic hernia lamb model. Crit Care Med 1995;23:1858-63.
24. Major D, Cadenas M, Cloutier R, Fournier L, Wolfson MR, Shaffer TH. Combined gas ventilation and perfluorochemical tracheal instillation as an alternative treatment for lethal congenital diaphragmatic hernia in lambs. J Pediatr Surg 1995;30:1178-82.
25. Shatter TH, Lowe CA, Bhutani VK, Douglas PR. Liquid ventilation: effects on pulmonary function in meconium stained lambs. Pediatr Res 1984;18:47-52.
26. Smith T, Steinhorn D, Thasu K, Fuhrman BP, Dandona P. A liquid perfluorochemical decreases the in-vitro production of reactive oxygen species by alveolar macrophages. Crit Care Med 1995;23:1533-9.
27. Greenspan JS, Wolfson MR, Rubenstein SD, Shatter TH. Liquid ventilation of human preterm neonates. J Pediatr 1990;117:106-11.
28. Hirschl RB, Pranikoff T, Gauger P, Schreiner RJ, Dechert R, Bartlett RH. Liquid ventilation in adults, children, and fullterm neonates. Lancet 1995;346:1201-2.
29. Hirschl RB, Pranikoff T, Wise C, Overbeck MC, Gauger P, Schreiner RJ, et al. Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome. JAMA 1996;275:383-9.
30. Guager PG, Pranikoff T, Schreiner RJ, Moler FW, Hirschl RB. Initial experience with partial liquid ventilation in pediatric patients with acute respiratory distress syndrome. Grit Care Med 1996;24:16-22.
31. Pranikoff T, Gauger P, Hirschl RB. Partial liquid ventilation in newborn patients with congenital diaphragmatic hernia. J Pediatr Surg 1996;31:613-8.
32. Garver KA, Kazerooni EA, Hirschl RB, DiPietro MA. Neonates with congenital diaphragmatic hernia: radiographic findings during partial liquid ventilation. Radiology 1996;200:219-23.
33. Toro-Figuera LO, Meliones JN, Curtis SE, Thompson AE, Hirschl RB, Fackler JC, et al. Perflubron partial liquid ventilation in children with ARDS: a safety and efficacy pilot study. Crit Care Med 1996;24: A150.
34. Bartlett RH, Roloff DW, Cornell RG, French Andrews A, Dillon PW, Zwischenberger JB. Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics 1985;76:479-87.
35. Chan V, Greenough A, Gamsu HR. High frequency oscillation for preterm infants with severe respiratory failure. Arch Dis Child 1994;70:F44-6.
36. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:819-20.
37. Loe WA, Graves ED, Ochsner JL, Falterman KW, Arensman RM. Extracorporeal membrane oxygenation in newborn respiratory failure. J Pediatr Surg 1985;20:684.
38. Short BL, Miller MK, Anderson KD. Extracorporeal membrane oxygenation in the management of respiratory failure in the newborn. Clin Perinatol 1987;14:737-48.
39. Krummel TM, Greenfield LJ, Kirkpatrick BV, Mueller DG, Kerkering KW, Ormazabal M, et al. Alveolar-arterial oxygen gradients versus the neonatal pulmonary insufficiency index for prediction of mortality in ECMO candidates. J Pediatr Surg 1984;19:380-4.
40. Beck R, Anderson KD, Pearson GD, Cronin J, Miller MK, Short BL. Criteria for extracorporeal membrane oxygenation in a population of infants with persistent pulmonary hypertension of the newborn. J Pediatr Surg 1986;21:297-302.
41. Kirkpatrick BV, Krummel TM, Mueller DG, Ormazabal MA, Greenfield LJ, Salzburg AM. Use of extracorporeal membrane oxygenation for respiratory failure in term infants. Pediatrics 1983;72:872-6.
42. Ortega M, Ramos AD, Platzker AC, Atkinson JB, Bowman CM. Early prediction of ultimate outcome in newborn infants with severe respiratory failure. J Pediatr 1988;113:744-7.
43. Bartlett RH, Toomasian J, Roloff D, Gazzaniga AB, Corwin AG, Rucker R. Extracorporeal membrane oxygenation (ECMO) in neonatal respiratory failure. Ann Surg 1986;204:236-44.
44. Richardson DK, Gray JE, McCormick MC, Workman K, Goldmann DA. Score for neonatal acute physiology: a physiologic severity index for neonatal intensive care. Pediatrics 1993;91:617-23.
45. International Neonatal Network. The CRIB (clinical risk index for babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet 1993;342:193-8.
46. Nading JH. Historical controls for extracorporeal membrane oxygenation in neonates. Crit Care Med 1989;17:423-5.
47. Dworetz AR, Moya FR, Sabo B, Gladstone I, Gross I. Survival of infants with persistent pulmonary hypertension without extracorporeal membrane oxygenation. Pediatrics 1989;84:1-6.
48. Kuint J, Reichman B, Neumann L, Shinwell ES. Prognostic value of the immediate response to surfactant. Arch Dis Child 1994;71:F170-3.
49. Segerer H, Stevens P, Schadow B, Maier R, Kattner E, Schwatz H, et al. Surfactant substitution in ventilated very low birth weight infants: factors related to response types. Pediatr Res 1991;30:591-6.
50. Collaborative European Multicentre Study Group. Factors influencing the clinical response to surfactant replacement therapy in babies with severe respiratory distress syndrome. Eur J Pediatr 1991;150:433-9.
51. Charon A, Taeusch HW, Fitzgibbon C, Smith GB, Treves ST, Phelps DS. Factors associated with surfactant treatment: response in infants with severe respiratory distress syndrome. Pediatrics 1989;83:348-54.
52. Fujiwara T, Konishi M, Chida S, Maeta H. Factors affecting the response to a postnatal single dose of a reconstituted bovine surfactant (Surfactant TA). In: Lachman B, ed. Surfactant replacement therapy in neonatal and adult respiratory distress syndrome. Berlin: Springer-Verlag, 1988:136-42.
53. Hamvas A, Devine T, Cole FS. Surfactant therapy failure identifies infants at risk for pulmonary mortality. Am J Dis Child 1993;147:665-8.